CYFRA 21-1 was identified in 1993 firstly as a valuable marker in lung cancer patients, which could be measured by a sandwich enzyme-linked immunosorbent assay to detect a soluble cytokeratin 19 fragment that is expressed in bronchial epithelium and malignant lung tumors. Here, KRT19 is linked to lung cancer.